19 June 2013
Keywords: UK, NICE, Merck Serono, Erbitux, Roche, Avastin, Amgen, Vectibix, Bristol-Myers, Pfizer, Eliquis
Article | 25 November 2011
In a batch of mixed news coming from the UK’s National Institute for Health and Clinical Excellence (NICE) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.